An ovine tracheal explant culture model for allergic airway inflammation.
BACKGROUND
The airway epithelium is thought to play an important role in the pathogenesis of asthmatic disease. However, much of our understanding of airway epithelial cell function in asthma has been derived from in vitro studies that may not accurately reflect the interactive cellular and molecular pathways active between different tissue constituents in vivo.


METHODS
Using a sheep model of allergic asthma, tracheal explants from normal sheep and allergic sheep exposed to house dust mite (HDM) allergen were established to investigate airway mucosal responses ex vivo. Explants were cultured for up to 48 h and tissues were stained to identify apoptotic cells, goblet cells, mast cells and eosinophils. The release of cytokines (IL-1α, IL-6 and TNF-α) by cultured tracheal explants, was assessed by ELISA.


RESULTS
The general morphology and epithelial structure of the tracheal explants was well maintained in culture although evidence of advanced apoptosis within the mucosal layer was noted after culture for 48 h. The number of alcian blue/PAS positive mucus-secreting cells within the epithelial layer was reduced in all cultured explants compared with pre-cultured (0 h) explants, but the loss of staining was most evident in allergic tissues. Mast cell and eosinophil numbers were elevated in the allergic tracheal tissues compared to naïve controls, and in the allergic tissues there was a significant decline in mast cells after 24 h culture in the presence or absence of HDM allergen. IL-6 was released by allergic tracheal explants in culture but was undetected in cultured control explants.


CONCLUSIONS
Sheep tracheal explants maintain characteristics of the airway mucosa that may not be replicated when studying isolated cell populations in vitro. There were key differences identified in explants from allergic compared to control airways and in their responses in culture for 24 h. Importantly, this study establishes the potential for the application of tracheal explant cultures in relevant ex vivo investigations on the therapeutic and mechanistic modalities of asthmatic disease.
Abeynaike
Latasha
L
Biotechnology Research Laboratories, Department of Physiology, School of Biomedical Sciences, Monash University, Clayton VIC 3800, Australia. rob.bischof@monash.edu.
Meeusen
Els Nt
EN
Bischof
Robert J
RJ
Eur Respir J. 2007 May;29(5):1020-32
17470623
J Allergy Clin Immunol. 2007 Dec;120(6):1279-84
17949801
Annu Rev Immunol. 2006;24:147-74
16551246
Int J Mol Med. 1998 Feb;1(2):367-78
9852239
Gene Ther. 1999 Apr;6(4):534-46
10476213
Clin Exp Allergy. 2008 Jun;38(6):872-97
18498538
J Reprod Immunol. 2004 Dec;64(1-2):45-58
15596226
J Biol Chem. 2002 Apr 26;277(17):14916-24
11839756
Pediatr Res. 2004 May;55(5):864-71
14764919
J Inflamm (Lond). 2008 Oct 20;5:16
18937841
J Allergy Clin Immunol. 1992 May;89(5):1001-9
1583242
Clin Exp Allergy. 2003 Mar;33(3):367-75
12614452
Pulm Pharmacol Ther. 2009 Oct;22(5):455-65
19393759
Am J Respir Crit Care Med. 1998 Aug;158(2):565-72
9700136
Clin Exp Allergy. 1998 Nov;28 Suppl 5:97-103
9988454
Immunology. 2002 Apr;105(4):375-90
11985658
Gene Ther. 2004 Nov;11(22):1659-64
15284837
Clin Exp Allergy. 2005 Feb;35(2):146-52
15725184
Exp Lung Res. 2006 Aug;32(7):321-30
17060175
Cell Mol Life Sci. 2007 May;64(10):1269-89
17364144
Am J Respir Cell Mol Biol. 2004 Dec;31(6):663-71
15347558
Am J Respir Cell Mol Biol. 1996 Jan;14(1):104-12
8534481
Gene Ther. 2001 Sep;8(18):1380-6
11571577
Eur J Immunol. 1996 Dec;26(12):2972-80
8977293
Am J Physiol Lung Cell Mol Physiol. 2004 Jul;287(1):L119-26
15020299
Psychosom Med. 2003 Sep-Oct;65(5):811-5
14508025
Eur Respir J. 2007 Feb;29(2):379-89
17264325
Am J Respir Crit Care Med. 1995 May;151(5):1354-8
7735584